Playback speed
10 seconds
Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce the Risk of Hospitalization and CV Mortality? Why Cardiologist Must Intervene in T2D?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Keith Ferdinand
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Keith Ferdinand
103 views
January 15, 2021
Login to view comments.
Click here to Login